Strategic Growth Laborie is a privately held, rapidly growing medical technologies company with a diverse portfolio across Urology, Gastroenterology, Gynecology, Obstetrics and Neonatology, presenting multiple cross-sell opportunities for adjacent diagnostics and consumables.

Acquisition Momentum Recent high-value asset moves and leadership changes, including Organon asset acquisitions and a new CEO, suggest a dynamic growth path and potential for partnerships or channel expansions to accelerate market penetration.

Digital & Compliance Adoption of a technology stack featuring .NET, continuous delivery, ISO 45001 and CCSP indicates a mature product development and quality/safety framework, enabling sales pitches around reliability, regulatory alignment and scalable integrations.

Financial Leverage Revenue scale in the low-to-mid hundreds of millions with investor-backed growth presents opportunities for bundled solutions, long-term contracts, and favorable pricing models to lock in multi-year procurement cycles.

Clinical & Customer Reach Global presence with hospitals, clinics, and academic centers, plus a leadership emphasis on patient-centered outcomes, opens doors for volume pilots, reference sites, and co-development with key clinical stakeholders to drive adoption.